Dual-targeted “OR-logic” gated CAR T cell therapy to achieve cure in multiple myeloma
Eric Smith, MD, PhD (Harvard Medical School/Dana-Farber Cancer Institute)
Development of allosteric EGFR inhibitor EAI-432 for non-small cell lung cancer
Michael Eck, MD, PhD (Harvard Medical School/Dana-Farber Cancer Institute) and David Scott (Dana-Farber Cancer Institute)
Off-the-shelf tissue for cartilage repair
April Craft, PhD (Harvard University/Boston Children’s Hospital)
Sidestepping iron restriction to treat anemia
Eric Gale, PhD (Harvard Medical School/Massachusetts General Hospital)
Enhancing activity of CAR T cells for the treatment of multiple myeloma
Mohammad Rashidian, PhD (Harvard Medical School/Dana-Farber Cancer Institute)
Eric Smith, MD, PhD (Harvard Medical School/Dana-Farber Cancer Institute)
Development of allosteric EGFR inhibitor EAI-432 for non-small cell lung cancer
Michael Eck, MD, PhD (Harvard Medical School/Dana-Farber Cancer Institute) and David Scott (Dana-Farber Cancer Institute)
Off-the-shelf tissue for cartilage repair
April Craft, PhD (Harvard University/Boston Children’s Hospital)
Sidestepping iron restriction to treat anemia
Eric Gale, PhD (Harvard Medical School/Massachusetts General Hospital)
Enhancing activity of CAR T cells for the treatment of multiple myeloma
Mohammad Rashidian, PhD (Harvard Medical School/Dana-Farber Cancer Institute)